Emergency medicine

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS15
Academic Journal
Presents an abstract of the research manuscript `High dose inhaled budesonide versus prednisone in patients with acute asthma (AA) discharged from the emergency department (ED),' by A. Grunfeld, A. Bai et al. Inhaled corticosteroid.


Related Articles

  • Corticosteroids Cause Unnecessary Bone Loss.  // Tufts University Health & Nutrition Letter;Jul2000, Vol. 18 Issue 5, p1 

    States that patients receiving long-term corticosteroid therapy may be subject to needless bone loss. Diseases being treated with corticosteroid drugs; Finding of researchers at the Medical College of Virginia when they surveyed patients taking prednisone everyday; Pieces of advice to prevent...

  • Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Shrewsbury, Stephen; Pyke, Stephen; Britton, Mark // BMJ: British Medical Journal (International Edition);05/20/2000, Vol. 320 Issue 7246, p1368 

    Features a study which aimed to examine the benefits of adding salmeterol compared with increasing dose of inhaled corticosteroids in symptomatic asthma. Methodology of the study; Results and discussion; Conclusions.

  • A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Chipps, Bradley E.; Chipps, Donna R. // Clinical Pediatrics;Apr2001, Vol. 40 Issue 4, p185 

    Summary: Systemic corticosteroids (CSs) are generally accepted as treatment for acute exacerbations of asthma. In contrast, inhaled corticosteroids (ICs) have been used for the long-term management of asthma but are not widely accepted for the treatment of asthma exacerbations. The onset of...

  • What is the optimal dose of inhaled corticosteroids in adult asthma? Chapman, Kenneth R. // Patient Care;2/1/1997, Vol. 31 Issue 2, p24 

    Focuses on the use of prescribe inhaled corticosteroids in higher doses to manage adult asthma. What is the optimal dose of inhaled corticosteroids in asthma; Explanations to be considered if patients with asthma do not respond well to dosages of inhaled corticosteroid under 1,000 a day; Why...

  • Review: Adding antileukotrienes to inhaled corticosteroids reduces exacerbations in symptomatic chronic asthma. Rees, P. John // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p99 

    Comments on a study which investigated the addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Results; Treatment which reduces the rate of exacerbations that require systemic corticosteroids; Effects of inhaled corticosteroids on asthma.

  • What are the Alternatives to Increasing Inhaled Corticosteroids for the Long Term Control of Asthma? Flood-Page, P.; Barnes, N.C. // BioDrugs;2001, Vol. 15 Issue 3, p185 

    The Global Initiative for Asthma (GINA) guidelines stated the therapeutic goals for the management of asthma and, through a stepwise approach to treatment, defined the various grades of asthma severity and the therapeutic options available to the clinician at each step. This article considers...

  • Inhaled vs. Systemic Corticosteroids in Asthma. Miller, Karl E. // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1107 

    Presents a study that hypothesized that the use of high-dosage, inhaled corticosteroids in hospitalized asthma patients could be as well tolerated and effective as oral corticosteroids. Use of systemic corticosteroids in the treatment of hospitalized asthma patients; Advantages of using inhaled...

  • Effects of reducing or discontinuing inhaled budenoside in patients with mild asthma. Schuster, Nancy B. // Physical Therapy;Apr1995, Vol. 75 Issue 4, p332 

    Presents an abstract of a study entitled `Effects of Reducing or Discontinuing Inhaled Budenoside in Patients With Mild Asthma,' by T. Haahtela, M. Jarvinen et al, published in the `New England Journal of Medicine.' Effect of inhaled costicosteroid on mild asthma.

  • Systemic safety of fluticasone furoate/vilanterol combination. Lipworth, Brian; Busse, William W.; Andersen, Leslie // Thorax;Dec2013, Vol. 68 Issue 12, p1164 

    A letter to the editor related to an article on the safety of fluticasone furoate/vilanterol combination in asthma by W.W. Busse, P.M. O'Byrne and E.R. Bleecker in the 2013 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics